Clinical Trial Update: Photodynamic Therapy in Occult-Only Lesions (POOL) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on photodynamic therapy for occult-only lesions in age-related macular degeneration; the study sponsored by Novartis has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Verteporfin (Visudyne) (verteporfin)

Snippet

Sponsor: Novartis | Conditions: Age-Related Macular Degeneration | Phase 4 | Status: COMPLETED